Barclays on U.S. Insurance/Life: We Favor MET Over PRU Ahead of Investor Days

May 18, 2012 3:18 PM EDT Send to a Friend
Get Alerts MET Hot Sheet
Price: $42.49 +0.54%

Rating Summary:
    9 Buy, 7 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 21 | Down: 24 | New: 29
Trade MET Now!
Barclays on U.S. Insurance/Life: We Favor MET Over PRU Ahead of Investor Days

Analyst, Jay Gelb, said, "MetLife (NYSE: MET) and Prudential Financial (NYSE: PRU) are hosting investor days in New York on May 23 and May 24, respectively. We prefer MET over PRU because MET offers a lower valuation as well as upside potential to earnings and ROE expectations from cost savings and share buybacks."

"MET (1-OW rated) appears well positioned to benefit from its diversified international platform as well as gains from its acquisition of Alico."

"PRU (2-EW rated) benefits from a strong global life insurance and asset management platform with half of earnings from outside the U.S (nearly all from Japan). However, PRU could face skepticism on its ability to achieve a 13%-14% ROE in 2013 (versus an annualized 1Q12 core operating ROE of 9.5%)."


Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here



You May Also Be Interested In


Related Categories

Analyst Comments

Related Entities

Barclays, Earnings

Add Your Comment